Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer
Publication
, Conference
Ahmed, I; Ferro, A; Wu, A; Haider, SA; Cohler, A; Langenfeld, J; Aisner, J; Surakanti, S; Zou, W; Jabbour, SK
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2014
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2014
Volume
90
Issue
1
Start / End Page
S634 / S634
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ahmed, I., Ferro, A., Wu, A., Haider, S. A., Cohler, A., Langenfeld, J., … Jabbour, S. K. (2014). Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer. In International Journal of Radiation Oncology*Biology*Physics (Vol. 90, pp. S634–S634). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2014.05.1882
Ahmed, I., A. Ferro, A. Wu, S. A. Haider, A. Cohler, J. Langenfeld, J. Aisner, S. Surakanti, W. Zou, and S. K. Jabbour. “Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 90:S634–S634. Elsevier BV, 2014. https://doi.org/10.1016/j.ijrobp.2014.05.1882.
Ahmed I, Ferro A, Wu A, Haider SA, Cohler A, Langenfeld J, et al. Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S634–S634.
Ahmed, I., et al. “Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer.” International Journal of Radiation Oncology*Biology*Physics, vol. 90, no. 1, Elsevier BV, 2014, pp. S634–S634. Crossref, doi:10.1016/j.ijrobp.2014.05.1882.
Ahmed I, Ferro A, Wu A, Haider SA, Cohler A, Langenfeld J, Aisner J, Surakanti S, Zou W, Jabbour SK. Survival Benefit With Carboplatin-Based Induction Chemotherapy for Bulky Stage II and III Inoperable Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2014. p. S634–S634.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2014
Volume
90
Issue
1
Start / End Page
S634 / S634
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences